Biogen
E3807
Biogen is a major American biotechnology company known for developing therapies for neurological and neurodegenerative diseases.
All labels observed (6)
| Label | Occurrences |
|---|---|
| Biogen canonical | 28 |
| Biogen Idec | 2 |
| Avonex | 1 |
| Biogen Inc. | 1 |
| Biogen Netherlands B.V. | 1 |
| NASDAQ:BIIB | 1 |
Statements (49)
| Predicate | Object |
|---|---|
| instanceOf |
biotechnology company
ⓘ
pharmaceutical company ⓘ public company ⓘ |
| areaServed | worldwide ⓘ |
| collaboratesWith |
Eisai
ⓘ
Ionis Pharmaceuticals ⓘ Genentech ⓘ
surface form:
Roche
|
| country |
United States of America
ⓘ
surface form:
United States
|
| focusesOn |
Alzheimer's disease
ⓘ
amyotrophic lateral sclerosis ⓘ multiple sclerosis ⓘ neurodegenerative diseases ⓘ neurological diseases ⓘ spinal muscular atrophy ⓘ |
| foundedBy |
Charles Weissmann
ⓘ
Heinz Schaller ⓘ Kenneth Murray ⓘ Nils Norman ⓘ Phillip A. Sharp ⓘ
surface form:
Phillip Allen Sharp
Walter Gilbert ⓘ |
| foundedIn |
1978
ⓘ
Geneva ⓘ |
| hasKeyTherapeuticArea |
ALS
ⓘ
Alzheimer's disease ⓘ Parkinson's disease ⓘ multiple sclerosis ⓘ spinal muscular atrophy ⓘ |
| hasNotableDrug |
Spinraza
ⓘ
Tecfidera ⓘ Tysabri ⓘ |
| hasProduct |
Aduhelm
ⓘ
Biogen self-linksurface differs ⓘ
surface form:
Avonex
Fampyra ⓘ Leqembi ⓘ Plegridy ⓘ Spinraza ⓘ Tecfidera ⓘ Tysabri ⓘ Vumerity ⓘ |
| hasResearchArea |
immunology
ⓘ
neuroscience ⓘ rare diseases ⓘ |
| headquartersLocation | Cambridge, Massachusetts ⓘ |
| industry |
biotechnology
ⓘ
pharmaceuticals ⓘ |
| specializesIn |
biologic therapies
ⓘ
monoclonal antibodies ⓘ small-molecule drugs ⓘ |
| tradedAs |
Biogen
self-linksurface differs
ⓘ
surface form:
NASDAQ:BIIB
|
Referenced by (34)
Full triples — surface form annotated when it differs from this entity's canonical label.
this entity surface form:
Avonex
this entity surface form:
Biogen Idec
this entity surface form:
Biogen Netherlands B.V.
subject surface form:
Biogen
this entity surface form:
Biogen Inc.
subject surface form:
Eisai
this entity surface form:
Biogen Idec